Biological optimization for mediastinal lymphoma radiotherapy – a preliminary study
<br><strong>Purpose: </strong>In current radiotherapy (RT) planning and delivery, population-based dose-volume constraints are used to limit the risk of toxicity from incidental irradiation of organs at risks (OARs). However, weighing tradeoffs between target coverage and doses to...
मुख्य लेखक: | Aznar, M |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
Taylor & Francis
2020
|
समान संसाधन
-
On the Importance of Individualized, Non-Coplanar Beam Configurations in Mediastinal Lymphoma Radiotherapy, Optimized With Automated Planning
द्वारा: Linda Rossi, और अन्य
प्रकाशित: (2021-04-01) -
Advanced Radiotherapy Techniques for Mediastinal Lymphomas: Results from an Italian Survey
द्वारा: Anna Di Russo, और अन्य
प्रकाशित: (2021-08-01) -
Nivolumab combined with brentuximab vedotin with or without mediastinal radiotherapy for relapsed/refractory primary mediastinal large B-cell lymphoma
द्वारा: Loic Renaud, और अन्य
प्रकाशित: (2024-05-01) -
Radiotherapy after immunochemotherapy improves outcomes in patients with primary mediastinal large B‐cell lymphoma
द्वारा: Agustin Avilés, और अन्य
प्रकाशित: (2019-12-01) -
Linfoma mediastinal en una lactante Mediastinal lymphoma in an infant
द्वारा: Delfín Chaveco Bautista, और अन्य
प्रकाशित: (2010-01-01)